Managing Tardive Dyskinesia with Proven Medications
Tardive dyskinesia (TD) primarily emerges from prolonged use of dopamine receptor-blocking drugs, leading to involuntary movements. Treatments like VMAT2 inhibitors, including deutetrabenazine and valbenazine, show promising results. Regular monitoring, medication adjustments, and advancing research offer hope for managing symptoms, with newer therapies enhancing patient outcomes and quality of life. Understanding Tardive Dyskinesia and its Treatments […]
3 minute read